271 related articles for article (PubMed ID: 20730877)
1. Demyelinating symmetric motor polyneuropathy with high titers of anti-GM1 antibodies.
O'Ferrall EK; White CM; Zochodne DW
Muscle Nerve; 2010 Oct; 42(4):604-8. PubMed ID: 20730877
[TBL] [Abstract][Full Text] [Related]
2. Demyelinating symmetric motor polyneuropathy with high anti-GM1 antibody titer: do we need to split?
Galassi G
Muscle Nerve; 2011 Jul; 44(1):147-8; author reply 148. PubMed ID: 21660986
[No Abstract] [Full Text] [Related]
3. Do GM1 antibodies induce demyelination?
Lange DJ; Trojaborg W
Muscle Nerve; 1994 Jan; 17(1):105-7. PubMed ID: 8264688
[TBL] [Abstract][Full Text] [Related]
4. Anti-GM1 antibodies in patients with chronic inflammatory demyelinating polyneuropathy (CIDP) treated with intravenous immunoglobulin (IVIg).
van Schaik IN; Vermeulen M; van Doorn PA; Brand A
J Neuroimmunol; 1994 Oct; 54(1-2):109-15. PubMed ID: 7929799
[TBL] [Abstract][Full Text] [Related]
5. [On the mechanisms and diagnosis of conduction disturbances due to demyelination with special reference to multifocal demyelinating neuropathy (Lewis-Sumner)].
Kaji R; Kimura J
Rinsho Shinkeigaku; 1991 Dec; 31(12):1330-2. PubMed ID: 1817801
[TBL] [Abstract][Full Text] [Related]
6. Anti-GM1 antibodies and impaired blood-nerve barrier may interfere with remyelination in multifocal motor neuropathy.
Kaji R; Hirota N; Oka N; Kohara N; Watanabe T; Nishio T; Kimura J
Muscle Nerve; 1994 Jan; 17(1):108-10. PubMed ID: 8264689
[TBL] [Abstract][Full Text] [Related]
7. Cerebellar ataxia and acute motor axonal neuropathy associated with Anti GD1b and Anti GM1 antibodies.
Bae JS; Kim BJ
J Clin Neurosci; 2005 Sep; 12(7):808-10. PubMed ID: 16054817
[TBL] [Abstract][Full Text] [Related]
8. Distal acquired demyelinating symmetric neuropathy associated with anti-GM1 antibodies: is this a CIDP variant?
Remiche G; Kentos A; Mavroudakis N
Acta Neurol Belg; 2010 Mar; 110(1):103-6. PubMed ID: 20514936
[TBL] [Abstract][Full Text] [Related]
9. [A case of chronic inflammatory demyelinating polyneuropathy with recurrent ophthalmoplegia, persistent conduction block, antibody activity against gangliosides GM1].
Ryo M; Saito T; Kunii N; Hasegawa H; Kowa H
Rinsho Shinkeigaku; 1994 Jul; 34(7):702-6. PubMed ID: 7955728
[TBL] [Abstract][Full Text] [Related]
10. The clinical correlates of high-titer IgG anti-GM1 antibodies.
Kornberg AJ; Pestronk A; Bieser K; Ho TW; McKhann GM; Wu HS; Jiang Z
Ann Neurol; 1994 Feb; 35(2):234-7. PubMed ID: 8109905
[TBL] [Abstract][Full Text] [Related]
11. Follow-up study and response to treatment in 23 patients with Lewis-Sumner syndrome.
Viala K; Renié L; Maisonobe T; Béhin A; Neil J; Léger JM; Bouche P
Brain; 2004 Sep; 127(Pt 9):2010-7. PubMed ID: 15289267
[TBL] [Abstract][Full Text] [Related]
12. [Antibodies to GM1 ganglioside in motor neuron disease--in comparison with demyelinating neuropathy].
Irie S; Saito T; Ogino M; Ito H; Kowa H
Rinsho Shinkeigaku; 1992 Oct; 32(10):1075-80. PubMed ID: 1297550
[TBL] [Abstract][Full Text] [Related]
13. High anti-GM1 and anti-GD1a IgG antibody titers are detected in Guillain-Barré syndrome but not in chronic inflammatory demyelinating polyneuropathy.
Tagawa Y; Yuki N; Hirata K
Eur Neurol; 2002; 48(2):118-9. PubMed ID: 12187004
[No Abstract] [Full Text] [Related]
14. Lower motor neuron syndrome associated with anti-GM1 antibodies.
Villa A; Molina H; Sanz OP; Garreto N; Kholer G; Sica RE
Medicina (B Aires); 1997; 57(3):270-4. PubMed ID: 9640758
[TBL] [Abstract][Full Text] [Related]
15. Lower motor neuron syndromes defined by patterns of weakness, nerve conduction abnormalities, and high titers of antiglycolipid antibodies.
Pestronk A; Chaudhry V; Feldman EL; Griffin JW; Cornblath DR; Denys EH; Glasberg M; Kuncl RW; Olney RK; Yee WC
Ann Neurol; 1990 Mar; 27(3):316-26. PubMed ID: 2327739
[TBL] [Abstract][Full Text] [Related]
16. [Motor-dominant neuropathy with multifocal conduction block].
Sonoo M; Inoue K; Kusunoki S; Fuji Y; Mannen T
Rinsho Shinkeigaku; 1990 Nov; 30(11):1214-20. PubMed ID: 2085927
[TBL] [Abstract][Full Text] [Related]
17. Association of IgM type anti-GM1 antibodies and muscle strength in chronic acquired demyelinating polyneuropathy.
Bech E; Andersen H; Orntoft TF; Jakobsen J
Ann Neurol; 1998 Jan; 43(1):72-8. PubMed ID: 9450770
[TBL] [Abstract][Full Text] [Related]
18. Multifocal motor neuropathy: association of anti-GM1 IgM antibodies with clinical features.
Cats EA; Jacobs BC; Yuki N; Tio-Gillen AP; Piepers S; Franssen H; van Asseldonk JT; van den Berg LH; van der Pol WL
Neurology; 2010 Nov; 75(22):1961-7. PubMed ID: 20962291
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of chronic immune-mediated polyneuropathies. State of the art and perspectives].
Léger JM; Chassande B
Ann Med Interne (Paris); 2000 May; 151 Suppl 1():1S19-23. PubMed ID: 10896984
[TBL] [Abstract][Full Text] [Related]
20. [A case of anti-GM1 antibody positive HTLV-I associated myelopathy (HAM) with polyneuropathy].
Yanagihara C; Ihara M; Nishimura Y; Oka N
Rinsho Shinkeigaku; 1999 Sep; 39(9):971-5. PubMed ID: 10614165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
